Covered recipient · General Payments record
CHANDAN NAYAK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$902.72
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.79 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.70 | 4 |
| Axsome Therapeutics, Inc. | $144.84 | 2 |
| Teva Pharmaceuticals USA, Inc. | $54.98 | 2 |
| Janssen Pharmaceuticals, Inc | $53.13 | 2 |
| Almatica Pharma Inc. | $18.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.53 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105105158 | CMS |
| ABBVIE INC. | $125.00 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105105160 | CMS |
| ABBVIE INC. | $11.26 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105105162 | CMS |
| ABBVIE INC. | $16.91 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105105164 | CMS |
| Almatica Pharma LLC | $18.14 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137572647 | CMS |
| Axsome Therapeutics, Inc. | $122.27 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148270584 | CMS |
| Axsome Therapeutics, Inc. | $22.57 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148270582 | CMS |
| Janssen Pharmaceuticals, Inc | $27.14 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078015002 | CMS |
| Janssen Pharmaceuticals, Inc | $25.99 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078015056 | CMS |
| Teva Pharmaceuticals USA, Inc. | $27.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151535117 | CMS |
| Teva Pharmaceuticals USA, Inc. | $27.98 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151535229 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.